ŸÀÌƲ
 

´ë°­´ç ¼Ò°­´ç ¿Ã¸¯ÇÈÆÄÅ©ÅÚ

2¿ù 25ÀÏ(±Ý)
~14:00 °³È¸¼±¾ð Local Organizing Committee (´ëȸÀå):
¿ï»êÀÇ´ë ¿Ü°ú È«¼®ÁØ
14:00-15:30 Symposium A: Thyroid and Metabolic Syndromes ÁÂÀå: ¼º±Õ°üÀÇ´ë ³»°ú ±è±¤¿ø
  Regulation of Whole Body Energy Metabolism and Role of Thyroid Hormone ¿ï»êÀÇ´ë ³»°ú ±è¹Î¼±
  Relationship between Thyroid Status and Metabolic Syndrome ¼­¿ïÀÇ´ë ³»°ú ¹Ú¿µÁÖ
  Thyroid Cancer and Obesity/Insulin Resistance Ãæ³²ÀÇ´ë ³»°ú Á¶¿µ¼®
14:00-15:30 Symposium B: Poorly and Undifferentiated thyroid cancer ÁÂÀå: ¾ÆÁÖÀÇ´ë ¿Ü°ú ¼ÒÀÇ¿µ
  Cytology and Pathology of Poorly and Undifferentiated Thyroid Cancer ¿¬¼¼ÀÇ´ë º´¸®°ú È«¼ø¿ø
  Current Status of Poorly Differentiated Thyroid Cancer in Korea ¿ï»êÀÇ´ë ³»°ú ±èÅ¿ë
  What is debating in Poorly and Undifferentiated Thyroid Cancer ¾ÆÁÖÀÇ´ë ¿Ü°ú ¼ÒÀÇ¿µ
15:30-15:50 Coffee break
15:50-16:50 Special Lecture ÁÂÀå (ÇÐȸÀå): °¡Å縯ÀÇ´ë ³»°ú À̱¤¿ì
  Current and Future Approach to Patients with Advanced Thyroid Cancer Univ. of Colorado, Denver, Bryan R. Haugen
16:50-18:20 ¿¬±¸ À§¿øȸ Seminar  
  Special Issues with Clinical Research ÁÂÀå: ¼º±Õ°üÀÇ´ë À̺ñÀÎÈÄ°ú ¼Õ¿µÀÍ
  1. Sample Size & Power Calculation °¡Å縯ÀÇ´ë ¿¹¹æÀÇÇаú ÀÓÇö¿ì
  2. Analysis of Continuous & Dichotomous Outcomes °í·ÁÀÇ´ë ÀÇÇÐÅë°èÇб³½Ç ¾ÈÇüÁø
  3. Survival Analysis ¿ï»êÀÇ´ë ¿¹¹æÀÇÇб³½Ç/ÀÇÇÐÅë°èÇб³½Ç À̹«¼Û
  4. How to Interpret Numbers (P-Value & Confidence Interval) ¼º±Õ°üÀÇ´ë »çȸÀÇÇб³½Ç ½Å¸íÈñ

Dinner Symposium : Advances in Management of Thyroid Cancer (ÁÂÀå : ¼º±Õ°üÀÇ´ë ³»°ú Á¤ÀçÈÆ)

ÀϽÃ: 2011³â 2¿ù 25ÀÏ (±Ý) 19:00~21:00 PM / Àå¼Ò: ¼ÛÆı¸ ¹æÀ̵¿ ¿Ã¸²ÇÈÆÄÅ©ÅÚ È£ÅÚ 2Ãþ ¼­¿ïȦ
19:00-21:00 1. How Recombinant Human TSH has Changed Our Approach to Thyroid Cancer Univ. of Colorado, Denver, Bryan R. Haugen
  2. ¹æ»ç¼º ¿ä¿Àµå Ä¡·á/Áø´Ü ½ºÄµ °Ë»ç½ÃÀÇ °©»ó¼±±â´ÉÀúÇÏÁõ (°¡Äª) °¡Å縯ÀÇ´ë ³»°ú ÀÓµ¿ÁØ